Welcome to LookChem.com Sign In|Join Free

CAS

  • or

191092-07-6

Post Buying Request

191092-07-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

191092-07-6 Usage

Description

(R)-3-(Tosyloxymethyl)-N-Boc-piperidine is a chemical compound featuring a piperidine ring with a tosyloxymethyl group and a Boc protecting group. The tosyloxymethyl group, a derivative of the toluenesulfonyl group, is frequently utilized as a leaving group in organic synthesis. The Boc protecting group serves to shield amines from unwanted reactions in organic chemistry. (R)-3-(Tosyloxymethyl)-N-Boc-piperidine is widely recognized for its role as a building block in the synthesis of various pharmaceuticals and other organic compounds, with its distinctive structure and reactivity making it a valuable asset in the realm of organic chemistry.

Uses

Used in Pharmaceutical Synthesis:
(R)-3-(Tosyloxymethyl)-N-Boc-piperidine is used as a key building block for the development of new pharmaceuticals. Its unique structure allows for the creation of a diverse range of medicinal compounds, contributing to advancements in drug discovery and design.
Used in Organic Chemistry Research:
In the field of organic chemistry, (R)-3-(Tosyloxymethyl)-N-Boc-piperidine is employed as a valuable tool for studying reaction mechanisms and exploring new synthetic pathways. Its reactivity and structural features facilitate the investigation of various organic reactions and the development of innovative methodologies.
Used in Chemical Synthesis Education:
(R)-3-(Tosyloxymethyl)-N-Boc-piperidine can also be utilized as an educational tool in teaching organic chemistry, particularly in illustrating the concepts of protecting groups, leaving groups, and the synthesis of complex organic molecules. Its structure and reactivity make it an ideal candidate for demonstrating various organic reactions and techniques in a controlled and educational setting.

Check Digit Verification of cas no

The CAS Registry Mumber 191092-07-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,1,0,9 and 2 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 191092-07:
(8*1)+(7*9)+(6*1)+(5*0)+(4*9)+(3*2)+(2*0)+(1*7)=126
126 % 10 = 6
So 191092-07-6 is a valid CAS Registry Number.

191092-07-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name (R)-3-(Tosyloxymethyl)-N-Boc-piperidine

1.2 Other means of identification

Product number -
Other names tert-butyl (3R)-3-({[(4-methylphenyl)sulfonyl]oxy}methyl)piperidine-1-carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:191092-07-6 SDS

191092-07-6Relevant articles and documents

Synthesis and in vitro evaluation of [18F](R)-FEPAQ: A potential PET ligand for VEGFR2

Prabhakaran, Jaya,Arango, Victoria,Majo, Vattoly J.,Simpson, Norman R.,Kassir, Suham A.,Underwood, Mark D.,Polavarapu, Hanish,Bruce, Jeffrey N.,Canoll, Peter,John Mann,Dileep Kumar

scheme or table, p. 5104 - 5107 (2012/09/07)

Synthesis and in vitro evaluation of [18F](R)-N-(4-bromo-2- fluorophenyl)-7-((1-(2-fluoroethyl)piperidin-3-yl)methoxy)-6-methoxyquinazolin- 4-amine ((R)-[18F]FEPAQ or [18F]1), a potential imaging agent for the VEGFR2, usin

NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS

-

Page/Page column 32-33, (2009/10/06)

Disclosed herein are compounds of formula (I) wherein R1, R2, R3, R25a, R26a, X, and n are as defined in the specification. Pharmaceutical compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and pharmaceutical compositions are also described

Novel Compounds

-

Page/Page column 52, (2008/06/13)

Compounds of Formulae I, or pharmaceutically acceptable salts thereof: wherein X, R1, R2 and R3 are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 191092-07-6